Research News
GW Cancer Center researchers found that PTEN, a tumor suppressor gene mutated in approximately 20% of primary prostate cancers, and in as many as 50% of androgen deprivation-resistant prostate cancers, relies on another gene, ARID4B, to function.
Raja Mazumder, PhD, professor of biochemistry and molecular medicine, authored a paper published in PLOS ONE outlining the baseline biome of a healthy human gut. This will serve as a reference for doctors, patients, and researchers, giving them an idea of what a “normal” human microbiome looks…
Antonia R. Sepulveda, MD, PhD, has been selected to serve as chair of the Department of Pathology at the GW School of Medicine and Health Sciences. She will also serve as the Ralph E. Lowey Professor of Oncology, as well as chief of pathology service and clinical laboratory director at GW…
Barbara Lee Bass, a widely respected academic medicine leader, surgeon and researcher who completed her residency and served on faculty at the GW, has been named vice president for health affairs and dean of the SMHS.
A team at the GW Cancer Center has identified the protein ERK as an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer.
A new survey published in the Journal of Drugs in Dermatology identifies several barriers that prevent the consistent use of fungal diagnostic preparations to correctly identify cutaneous fungal infections.
The GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma. The study is led by Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the GW Cancer Center.
The GW is pleased to announce that the GW Biorepository is now a core facility. Housed at the GW School of Medicine and Health Sciences, the GW Biorepository received designation as a shared resource available to all GW investigators and is accredited by the College of American Pathologists.
Ali Ahmed, MD, MPH, professor of medicine, was the senior author and Richard M. Allman, MD, clinical professor of medicine, was a co-author on a paper that found stopping digoxin in some patients with heart failure is linked to higher risk of death and hospital readmission.
A research team led by Yanfen Hu, PhD, is studying the role of the tumor suppressor BRCA1 in the homologous recombination pathway of DNA double-strand break repair.